Securing a Supply of Isotopes Within a Radioisotope Agnostic Portfolio
- Advancing next-generation isotopes and their potential to transform targeted radioligand therapy
- Strengthening global production and partnership networks to ensure reliable, scalable supply
- Addressing the challenges of introducing a novel isotope in the absence of extensive clinical data while maintaining supply chain integrity